Cerus
CERS • NASDAQ
Cerus is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO William Greenman, with a market cap of $342.1M.
CEOWilliam Greenman
Next Earnings
Upcoming earnings announcement for Cerus
Date
Thursday, April 30, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.03
Revenue Estimate
$51.2M
Earnings History
Past 12 earnings reports for Cerus
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 2, 2026 | Q4 2025 | -$0.01Est: -$0.01 | 0.0% | $57.8MEst: $59.3M | -2.6% |  10-K |
| Nov 6, 2025 | Q3 2025 | $0.00Est: -$0.02 | +100.0% | $52.7MEst: $55.1M | -4.4% | 10-Q |
| Aug 5, 2025 | Q2 2025 | -$0.03Est: -$0.02 | -50.0% | $52.4MEst: $51.8M | +1.3% | 10-Q |
| May 1, 2025 | Q1 2025 | -$0.04Est: -$0.05 | +20.0% | $43.2MEst: $47.4M | -8.9% | 10-Q |
| Feb 20, 2025 | Q4 2024 | -$0.01Est: -$0.01 | 0.0% | $50.8MEst: $53.0M | -4.0% | 10-K |
| Oct 30, 2024 | Q3 2024 | -$0.02Est: -$0.03 | +33.3% | $46.0MEst: $47.3M | -2.8% | 10-Q |
| Aug 1, 2024 | Q2 2024 | -$0.03Est: -$0.04 | +25.0% | $45.1MEst: $46.6M | -3.3% | 10-Q |
| May 2, 2024 | Q1 2024 | -$0.05Est: -$0.05 | 0.0% | $38.4MEst: $41.1M | -6.7% | 10-Q |
| Mar 5, 2024 | Q4 2023 | -$0.01Est: -$0.02 | +50.0% | $46.8MEst: $49.3M | -5.1% | 10-K |
| Nov 2, 2023 | Q3 2023 | -$0.04Est: -$0.05 | +20.0% | $39.8MEst: $42.5M | -6.4% | — |
| Aug 2, 2023 | Q2 2023 | -$0.07Est: -$0.05 | -40.0% | $38.9MEst: $40.8M | -4.8% | 10-Q |
| May 4, 2023 | Q1 2023 | -$0.09Est: -$0.07 | -28.6% | $31.0MEst: $34.8M | -11.1% | — |